Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Incident mental illness -- most commonly, depression and anxiety -- affected 8.4% of mothers with MS prenatally and 14.2% ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

Columnist Ben Hofmeister reflects on his journey treating depression and what he wishes he knew earlier about MS and mental health.

FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...